1、Developing an Analytical Framework for mRNAExcipients Impact Stability in mRNA-LNP FormulationsThe Economics of Synthetic mRNA Capping StrategiesLogistical Considerations in mRNA Vaccine DevelopmentExploring mRNAs PotentialAll Things mRNA Strategies for Effective mRNA Vaccine and Therapeutic Develop

2、mentJUNE 2024This custom ebook is sponsored by TriLink BioTechnologies,part of Maravai LifeSciences,and presented in partnership with BioPharm International.The Economics of Synthetic mRNA Capping StrategiesDeveloping an Analytical Framework for mRNAExcipients Impact Stability in mRNA-LNP Formulatio

3、nsLogistical Considerations in mRNA Vaccine DevelopmentExploring mRNAs PotentialJUNE 2024|BIOPHARM INTERNATIONAL SPONSORED CONTENT2 Exploring mRNAs PotentialChris Spivey,Editorial Director of Pharmaceutical Technology,hosts a wide-ranging discussion on the COVID-19 pandemic response,future governmen

4、t communications,and healthcare funding for mRNA with experts Dr.Kate Broderick,Chief Innovation Officer at Maravai LifeSciences,and Dr.Tom Madden,President&CEO at Acuitas Therapeutics.Highlights include supply chain modalities,ensuring a fully trained manufacturing workforce,combining delivery with

5、 gene-editing innovations,and epigenetic approaches to modulate gene expression moving toward the clinic.We conclude with the huge potential for RNA expression of monoclonal antibodies and protein replacement applications.Cover:Adapted from xyz+/ and Dr_Microbe/;Above:Matthieu/The Economics of Synth

6、etic mRNA Capping StrategiesDeveloping an Analytical Framework for mRNAExcipients Impact Stability in mRNA-LNP FormulationsLogistical Considerations in mRNA Vaccine DevelopmentExploring mRNAs PotentialJUNE 2024|BIOPHARM INTERNATIONAL SPONSORED CONTENT3 PharmTech:Thank you very much for making the ti